News Wave Life Sciences Ltd.

Equities

WVE

SG9999014716

Market Closed - Nasdaq Other stock markets 01:30:00 27/04/2024 am IST			5-day change	1st Jan Change
4.66 ^USD	-1.69%		-4.31%	-7.72%

23/04	Wave Life Sciences Ltd. Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing	CI
12/03	Mizuho Adjusts Price Target on WAVE Life Sciences to $19 From $10, Maintains Buy Rating	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing	23/04	GL
Wave Life Sciences Ltd. Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing	23/04	CI
Wave Life Sciences to Present at Upcoming Investor Conferences	27/03	GL
Mizuho Adjusts Price Target on WAVE Life Sciences to $19 From $10, Maintains Buy Rating	12/03	MT
H.C. Wainwright Adjusts Price Target on WAVE Life Sciences to $15 From $8, Maintains Buy Rating	07/03	MT
Sector Update: Health Care Stocks Higher Late Afternoon	07/03	MT
WAVE Life Sciences Shares Surge After Q4 Beats Estimates	07/03	MT
Transcript : Wave Life Sciences Ltd., Q4 2023 Earnings Call, Mar 06, 2024	06/03
Wave Life Sciences: Q4 Earnings Snapshot	06/03	AQ
Wave Life Sciences Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	06/03	CI
Wave Life Sciences Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	06/03	CI
Earnings Flash (WVE) WAVE LIFE SCIENCES USA Reports Q4 Revenue $29.1M, vs. Street Est of $19.8M	06/03	MT
Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	06/03	GL
Wave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Scheduled for March 6, 2024	28/02	GL
Wave Life Sciences Announces Upcoming Presentations at MDA Conference that Highlight Best-in-Class Potential for WVE-N531 in Duchenne Muscular Dystrophy	27/02	GL
Transcript : Wave Life Sciences Ltd. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 03:00 PM	11/01
Wave Life Sciences Highlights Recent Achievements and Upcoming 2024 Milestones	08/01	GL
Wave Life Sciences to Present at 42nd Annual J.P. Morgan Healthcare Conference	03/01	GL
Leerink Partners Upgrades WAVE Life Sciences to Outperform From Market Perform, Price Target at $12	19/12	MT
Wave Life Sciences Announces Initiation of Dosing in Phase 2 FORWARD-53 Trial of WVE-N531 in Duchenne Muscular Dystrophy	18/12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Wave Life Sciences Ltd.

Equities

WVE

SG9999014716

Summary

Filters